About: New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1983

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en 1983 (ast) articolo scientifico (pubblicato il 1983) (it) artigo científico (publicado na 1983) (pt) наукова стаття, опублікована в січні 1983 (uk) article scientifique publié en 1983 (fr) im Januar 1983 veröffentlichter wissenschaftlicher Artikel (de) 1983 թվականի հունվարի 1-ին հրատարակված գիտական հոդված (hy) artikull shkencor i botuar më 01 janar 1983 (sq) scientific article published on 01 January 1983 (en)
publication date	wds:Q70452977-5427276C-638F-4C52-9AB0-E30DBCC1DB93
publication date	1983-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q70452977-3EF66D95-9417-4B54-ADD1-A5FBD0DD7142 wds:Q70452977-470BD5E4-855B-4835-B9E7-E44D2EFC9938 wds:Q70452977-6CDA6A73-83B9-47EA-AC32-E8E661A3D463 wds:Q70452977-7B33DE0B-7E73-4E57-A182-D0E669DC6962 wds:Q70452977-7E70B1AD-19AE-4E1E-BA7F-84A7B118ACED wds:Q70452977-8FE7C1D6-10F6-4AC0-8229-FEE58F467E17 wds:Q70452977-94123E1B-790F-4D00-B78E-72C5098DE134 wds:Q70452977-9640B6EE-13D2-4BA3-BC97-B421A971DEF5 wds:Q70452977-A6BE130A-1A5B-43AD-8112-E2FBCE391E2C wds:Q70452977-F0E6E6CB-060B-4875-BED9-AA940940AB09
author name string	F Labrie A Dupont A Belanger J M Husson J Sandow J P Raynaud G Monfette A T Fazekas J Gareau Y Lacoursiere
rdfs:label	New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (en) New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (nl) New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (sq)
skos:prefLabel	New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (en) New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (nl) New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (sq)
name	New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (en) New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (nl) New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (sq)
title	wds:Q70452977-DB2193D4-6F77-4F5A-A924-7CA4C1744EDA
title	New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens (en)
page(s)	wds:Q70452977-A274E754-1861-49B1-BFA2-68C6782CDDA5
page(s)	579-594
instance of	wds:Q70452977-95687277-3B32-4B20-80AC-B7A5D7FBB27C
instance of	scholarly article
main subject	wds:Q70452977-9D3F569D-DCE4-45DF-86E3-7334927416EE
main subject	prostate cancer
PubMed ID	wds:Q70452977-7C678BC0-E710-4895-8657-7AC99AE39B2E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6415630
PubMed ID	6415630
published in	wds:Q70452977-A90E1F8A-C612-436C-A9B8-0AD767454219
published in	The Prostate
issue	wds:Q70452977-4E53437C-DC5A-4439-8E15-FBAB33E15D11
volume	wds:Q70452977-BB1437CB-7A58-4038-A7CB-F504475180CB
issue	6
volume	4
DOI	wds:Q70452977-112EF930-EA34-4BF1-91F3-19B67FB7AE27
DOI	http://dx.doi.org/10.1002/PROS.2990040605
DOI	10.1002/PROS.2990040605
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70452977
is cites work of	Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations Prostate carcinoma: defining therapeutic objectives and improving overall outcomes Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target Therapeutic effects of leuprorelin microspheres in prostate cancer Developments in the control of testicular function Consideration of the use of 17?-N,N-diethylcarbamoyl-4-methyl-4-aza-5-?-androstan-3-one (4MA), a 5?-reductase inhibitor, in prostate cancer therapy Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy Prostate cancer: a comprehensive review Hormonal management of prostate cancer 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro]. Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy Endocrine Therapy for Prostate Cancer Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2 Intermittent androgen suppression in the management of prostate cancer The andropause: fact or fiction? Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma Urology: treatment of cancer of the prostate Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model Prostate cancer: a dynamic illness with shifting targets Abiraterone in the treatment of metastatic castration-resistant prostate cancer Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model The evolution of hormonal therapy for prostatic carcinoma Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules Recovery of Gonadal Functions in the Adult Male Rat Following Cessation of Five-month Daily Treatment with an LHRH Agonist Efficacy and advantages in the use of low doses of anandron and estrogen combination in the treatment of prostate cancer Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH. Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience A new approach in the hormonal treatment of prostate cancer: complete instead of partial blockade of androgens A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate The role of endocrine therapy in prostatic cancer The pure antiandrogen ru 23908 (anandron®), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review [Problems and principles of hormone therapy of advanced prostate cancer].

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software